Many women have been hesitant or unable to attend health care visits because of the COVID-19 pandemic, leading to thousands of missed annual wellness visits, vaccinations, and cancer screenings.
During the COVID-19 pandemic, more clinicians than ever are turning to telehealth. But one group of providers has been seeing patients virtually for years: genetic counselors.
At an SWHR roundtable, experts and patients identified gaps in research, clinical practice, policy, and education related to HPV-associated diseases.
SWHR hosted three value assessment experts at its recent policy meeting to discuss the integration of women’s health priorities into assessments of new health care innovations.
Anal cancer is a rare and incredibly stigmatized disease — and the majority of cases in the U.S. occur in women.
In the midst of COVID-19, pregnant women and new moms are being forced to confront unexpected challenges and possible worst-case scenarios about delivery and the postpartum period.
ICER's updated value assessment framework embraces several of SWHR’s recommendations, but more work remains to adequately evaluate the value of health care interventions for women.
Some of screening and diagnostic tests for women are woefully outdated or nonexistent, resulting in uncertainties about their disease risk and difficulty with diagnosis.
Menstrual products are as essential as toilet paper — and for some women equally as hard to find during the COVID-19 pandemic.
Women are more prone to certain sleep difficulties than men. Now, the COVID-19 pandemic is exacerbating these sleep problems.